InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Lexaria Bioscience Corp.

LEXX Clue Score45
British Columbia, Canada Fiscal year ends August CIK 0001348362
$3.32 +3.75% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.32 −50.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.1Net income−1.9Fiscal year 2018Revenue0.4 +580.9%Net income−6.6Fiscal year 2019Revenue0.2 −48.6%Net income−4.2Fiscal year 2020Revenue0.4 +72.7%Net income−4.1Fiscal year 2021Revenue0.7 +87.9%Operating income−5.7Net income−4.0Fiscal year 2022Revenue0.3 −64.7%Operating income−6.6Net income−7.3Fiscal year 2023Revenue0.2 −11.4%Operating income−6.5Net income−6.7EPS, diluted−1.01Fiscal year 2024Revenue0.5 +105.2%Operating income−5.8Net income−5.8EPS, diluted−0.47Fiscal year 2025Revenue0.7 +52.0%Operating income−11.9Net income−11.9EPS, diluted−0.66
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.4 0.2 0.4 0.7 0.3 0.2 0.5 0.7
Growth +580.9% −48.6% +72.7% +87.9% −64.7% −11.4% +105.2% +52.0%
Operating income n/a n/a n/a n/a −5.7 −6.6 −6.5 −5.8 −11.9
Net income −1.9 −6.6 −4.2 −4.1 −4.0 −7.3 −6.7 −5.8 −11.9
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −1.01 −0.47 −0.66

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin53.3%Net margin−3,031.9%Free cash flow margin−2,429.2%Fiscal year 2018Gross margin94.2%Net margin−1,525.4%Fiscal year 2019Gross margin89.7%Net margin−1,868.0%Free cash flow margin−1,640.4%Fiscal year 2020Gross margin56.0%Net margin−1,062.2%Free cash flow margin−681.0%Fiscal year 2021Gross margin75.7%Operating margin−786.8%Net margin−557.2%Fiscal year 2022Gross margin71.9%Operating margin−2,591.7%Net margin−2,846.3%Free cash flow margin−1,929.8%Fiscal year 2023Gross margin86.1%Operating margin−2,888.5%Net margin−2,946.4%Free cash flow margin−2,614.8%Fiscal year 2024Gross margin99.0%Operating margin−1,239.2%Net margin−1,248.2%Free cash flow margin−1,077.4%Fiscal year 2025Gross margin99.6%Operating margin−1,683.0%Net margin−1,686.0%Free cash flow margin−1,483.9%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 53.3% 94.2% 89.7% 56.0% 75.7% 71.9% 86.1% 99.0% 99.6%
Operating margin n/a n/a n/a n/a −786.8% −2,591.7% −2,888.5% −1,239.2% −1,683.0%
Net margin −3,031.9% −1,525.4% −1,868.0% −1,062.2% −557.2% −2,846.3% −2,946.4% −1,248.2% −1,686.0%
Free cash flow margin −2,429.2% n/a −1,640.4% −681.0% n/a −1,929.8% −2,614.8% −1,077.4% −1,483.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−1.5Capital expenditure0.0Free cash flow−1.5Fiscal year 2018Operating cash flow−2.5Fiscal year 2019Operating cash flow−3.0Capital expenditure−0.6Free cash flow−3.7Fiscal year 2020Operating cash flow−2.6Capital expenditure0.0Free cash flow−2.6Fiscal year 2021Operating cash flow−4.0Fiscal year 2022Operating cash flow−4.9Capital expenditure−0.0Free cash flow−4.9Fiscal year 2023Operating cash flow−5.9Capital expenditure−0.0Free cash flow−5.9Fiscal year 2024Operating cash flow−5.0Capital expenditure−0.0Free cash flow−5.0Fiscal year 2025Operating cash flow−10.5Capital expenditure−0.0Free cash flow−10.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.5 −2.5 −3.0 −2.6 −4.0 −4.9 −5.9 −5.0 −10.5
Capital expenditure 0.0 n/a −0.6 0.0 n/a −0.0 −0.0 −0.0 −0.0
Free cash flow −1.5 n/a −3.7 −2.6 n/a −4.9 −5.9 −5.0 −10.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash2.5Shareholders’ equity2.8Fiscal year 2018Cash1.7Shareholders’ equity2.4Fiscal year 2019Cash1.3Shareholders’ equity2.5Fiscal year 2020Cash1.3Shareholders’ equity2.5Fiscal year 2021Cash10.9Shareholders’ equity13.3Fiscal year 2022Cash5.8Shareholders’ equity7.9Fiscal year 2023Cash1.4Shareholders’ equity3.0Fiscal year 2024Cash6.5Shareholders’ equity8.0Fiscal year 2025Cash1.8Shareholders’ equity3.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.5 1.7 1.3 1.3 10.9 5.8 1.4 6.5 1.8
Shareholders’ equity 2.8 2.4 2.5 2.5 13.3 7.9 3.0 8.0 3.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending August, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Aug 2017 FY2018 31 Aug 2018 FY2019 31 Aug 2019 FY2020 31 Aug 2020 FY2021 31 Aug 2021 FY2022 31 Aug 2022 FY2023 31 Aug 2023 FY2024† 31 Aug 2024 FY2025 31 Aug 2025
Operations
−1.5 −2.5 −3.0 −2.6 −4.0 −4.9 −5.9 −5.0 −10.5
Growth
n/a n/a n/a n/a n/a n/a n/a 0.0 0.1
Investment
0.0 n/a −0.6 0.0 n/a −0.0 −0.0 −0.0 −0.0
calc −1.5 n/a −3.7 −2.6 n/a −4.9 −5.9 −5.0 −10.5
Growth
calc n/a n/a n/a n/a n/a n/a −0.89 −0.40 −0.58
−0.0 −0.2 −0.8 −0.0 0.2 −0.2 −0.2 −0.2 −0.2
Financing
4.0 1.9 3.3 2.7 13.4 −0.0 1.6 10.3 6.0

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.